Last reviewed · How we verify
NCT05459142
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan.
trial testing Medical Abortion in Pregnancy Related in 50 participants. Completed in 30 November 2022.
30 November 2022
Quick facts
| Lead sponsor | Gynuity Health Projects |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 June 2022 |
| Primary completion | 30 November 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across Azerbaijan |
Drugs / interventions tested
- Medical Abortion — full drug profile →
Conditions studied
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
Gynuity Health Projects — full company profile →
Who can join
Eligibility, female only, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to pilot and evaluate a telemedicine medical abortion service delivery that allows remote communication between the woman and provider and limits medically unnecessary in-person visits to health or diagnostic centers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05459142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Medical Abortion
Trials testing the same drug.
- NCT03931460 — Feasibility of Medical Abortion by Telemedicine in Mexico · completed
Other recruiting trials for Pregnancy Related
Currently open trials in the same condition.
- NCT05909761 — Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregn · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
- NCT07518550 — Maternal and Fetal Electrocardiograms Separation Algorithm · NA · recruiting
- NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting
Other Gynuity Health Projects trials
Trials by the same sponsor.
- NCT06492889 — Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens · Phase 2, PHASE3 · not yet recruiting
- NCT05781061 — MA-ASAP at Independent Abortion Clinics: A Demonstration Project · NA · completed
- NCT05119439 — Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks · Phase 4 · terminated
- NCT05278780 — Medication Abortion With Autonomous Self-Assessment Project · NA · completed
- NCT05207644 — Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05459142 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gynuity Health Projects
- Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05459142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing